92 related articles for article (PubMed ID: 1356615)
1. Establishment of the human BSMZ breast cancer cell line, which overexpresses the erbB-2 and c-myc genes.
Watanabe M; Tanaka H; Kamada M; Okano JH; Takahashi H; Uchida K; Iwamura A; Zeniya M; Ohno T
Cancer Res; 1992 Oct; 52(19):5178-82. PubMed ID: 1356615
[TBL] [Abstract][Full Text] [Related]
2. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
3. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
4. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
5. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J
Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
8. Assessing sequential oncogene amplification in human breast cancer.
Janocko LE; Lucke JF; Groft DW; Brown KA; Smith CA; Pollice AA; Singh SG; Yakulis R; Hartsock RJ; Shackney SE
Cytometry; 1995 Sep; 21(1):18-22. PubMed ID: 8529465
[TBL] [Abstract][Full Text] [Related]
9. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
Lavialle C; Modjtahedi N; Cassingena R; Brison O
Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
Li BD; Bauer KD; Carney WP; Duda RB
J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor.
Handgretinger R; Kimmig A; Koscielnak E; Schmidt D; Rudolph G; Wolburg H; Paulus W; Schilbach-Stueckle K; Ottenlinger C; Menrad A
Cancer Res; 1990 Apr; 50(7):2177-82. PubMed ID: 2180563
[TBL] [Abstract][Full Text] [Related]
12. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
[TBL] [Abstract][Full Text] [Related]
13. Effects of c-myc overexpression on the growth characteristics of MCF-7 human breast cancer cells.
Liu E; Santos G; Lee WM; Osborne CK; Benz CC
Oncogene; 1989 Aug; 4(8):979-84. PubMed ID: 2668848
[TBL] [Abstract][Full Text] [Related]
14. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.
Kreipe H; Feist H; Fischer L; Felgner J; Heidorn K; Mettler L; Parwaresch R
Cancer Res; 1993 Apr; 53(8):1956-61. PubMed ID: 8096798
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells.
Dati C; Antoniotti S; Taverna D; Perroteau I; De Bortoli M
Oncogene; 1990 Jul; 5(7):1001-6. PubMed ID: 1973827
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
17. Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.
Mehta RR; Bratescu L; Graves JM; Hart GD; Shilkaitis A; Green A; Beattie CW; Das Gupta TK
Anticancer Res; 1992; 12(3):683-92. PubMed ID: 1377894
[TBL] [Abstract][Full Text] [Related]
18. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of c-erbB-2 and c-myc but not c-ras, in canine melanoma cell lines, is associated with metastatic potential in nude mice.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Anticancer Res; 1993; 13(5A):1365-71. PubMed ID: 8239507
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.
Emoto M; Oshima K; Ishiguro M; Iwasaki H; Kawarabayashi T; Kikuchi M
Pathol Res Pract; 1999; 195(4):237-42. PubMed ID: 10337661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
